ZBH · Zimmer Biomet Holdings, Inc.
$90.892026-05-17Sector: Healthcare; Industry: Medical - Devices; Sub-Industry: Health Care Equipment
Intrinsic Value Range Comparison · Mulya.ai
R&D capitalized (5yr)Base · active
$61
-32.9% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($61 · $87) Analysts Range ($89 · $122) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $6.8B | — | 13.7% | 6.3% | $879MM | $634MM | $1.5B | 5.4% | — | 4.3% | $20.6B | $2.03 | — |
| 2022.Q4 | $6.9B | 1.6% | 10.9% | 27.8% | $548MM | $115MM | $663MM | 6.5% | — | 2.8% | $18.5B | $1.17 | — |
| 2023.Q4 | $7.4B | 6.5% | 18.8% | 4.0% | $1.3B | −$82MM | $1.3B | 6.7% | — | 7.1% | $19.2B | $5.17 | — |
| 2024.Q4 | $7.7B | 3.8% | 18.3% | 12.7% | $1.2B | −$198MM | $1.0B | 7.2% | — | 6.3% | $19.4B | $4.56 | — |
| 2025.Q4 | $8.2B | 7.2% | 16.3% | 15.1% | $1.1B | −$213MM | $926MM | 7.0% | — | 5.6% | $21.0B | $3.56 | 13.4 |
| italics below = DCF projection · 10yr Rev CAGR: 4.3% |
| 2026.Q4 | $8.6B | +4.0% | 18.1% | 15.6% | $1.3B | −$260MM | $1.0B | 8.0% | $968MM | 6.2% | $21.2B | $6.05 | 15.0 |
| 2027.Q4 | $8.9B | +4.0% | 18.8% | 16.1% | $1.4B | −$293MM | $1.1B | 8.1% | $952MM | 6.6% | $21.5B | $6.50 | 14.0 |
| 2028.Q4 | $9.3B | +4.0% | 19.0% | 16.6% | $1.5B | −$334MM | $1.1B | 8.1% | $898MM | 6.8% | $21.9B | $6.79 | 13.4 |
| 2029.Q4 | $9.7B | +5.3% | 19.8% | 17.1% | $1.6B | −$504MM | $1.1B | 8.2% | $802MM | 7.2% | $22.4B | $7.41 | 12.3 |
| 2030.Q4 | $10.2B | +5.2% | 19.8% | 17.6% | $1.7B | −$584MM | $1.1B | 8.3% | $737MM | 7.4% | $22.9B | $7.75 | 11.7 |
|
| Term. Yr+ | $13.0B | 4.1% | 19.4% | 20.0% | $2.0B | −$961MM | $1.1B | 8.6% | $10.6B | 8.6% | — | — | — |
Active scenario IV: $61 (-32.9% vs market)